Clinical trial · Observational
Testing a Personalize Medication Log for Patients With Lymphoma
NCT02370446CI-TRIAL-00025440completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional information is helpful and if having this additional information about their treatment schedule has an effect on their quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cognitive Interview | Behavioral | — | UNRESOLVED |
| personalized medication log | Other | — | UNRESOLVED |
| questionnaires | Behavioral | — | UNRESOLVED |
| standard of care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- patient gets personalized medication log
- description
- Patients in the intervention group will receive a personalized medication log that includes all treatment medications (IV and oral), days of treatment and medication specific information such as timing or diet restrictions. The personalized medication log and patient education materials (fact cards) will be placed in a clear plastic envelope that the patient can carry with them throughout treatment.
- interventionNames
- Other: personalized medication log
- Behavioral: questionnaires
- Behavioral: Cognitive Interview
- label
- patient gets standard of care
- description
- Current MSKCC standards of professional nursing practice require the professional nurse to develop a plan of care that includes teaching the patient and support system the prescribed prescriptions / regimen and all doses, route, length of treatment, side effects and safety precautions.
- interventionNames
- Other: standard of care
- Behavioral: questionnaires
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of lymphoma * No prior treatment for lymphoma * Scheduled to receive CHOP14 +/- Rituximab, CEOP 21, CHOPE or EPOCH +/- Rituximab * Age 18 or older * Able to speak and read English Exclusion Criteria: * Documented major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.